Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Shepherd

Showing results (541-550 of 545) with videos related to

Pageof 55
Sort By:
You have reached the last page of results.This site can display upto 545 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2017
Veliparib with temozolomide or carboplatin/paclitaxel versus placebo with carboplatin/paclitaxel in patients with BRCA1/2 locally recurrent/metastatic breast cancer: randomized phase II studyH S Han, V Diéras, M Robson, et al.
Elife|November 12, 2020
A versatile oblique plane microscope for large-scale and high-resolution imaging of subcellular dynamicsEtai Sapoznik, Bo-Jui Chang, Jaewon Huh, et al.
Gynecologic Oncology|January 29, 2019
53BP1 as a potential predictor of response in PARP inhibitor-treated homologous recombination-deficient ovarian cancerRachel M Hurley, Andrea E Wahner Hendrickson, Daniel W Visscher, et al.
Cancer Chemotherapy and Pharmacology|April 18, 2022
A phase 1 and pharmacodynamic study of chronically-dosed, single-agent veliparib (ABT-888) in patients with BRCA1- or BRCA2-mutated cancer or platinum-refractory ovarian or triple-negative breast cancerJulia Manzo, Shannon Puhalla, Shalu Pahuja, et al.
Nature Medicine|June 8, 2023
An integrated cell atlas of the lung in health and diseaseLisa Sikkema, Ciro Ramírez-Suástegui, Daniel C Strobl, et al.
Pageof 55

Showing results (541-550 of 545) with videos related to

Sort By:
Pageof 55
You have reached the last page of results.This site can display upto 545 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2017
Veliparib with temozolomide or carboplatin/paclitaxel versus placebo with carboplatin/paclitaxel in patients with BRCA1/2 locally recurrent/metastatic breast cancer: randomized phase II studyH S Han, V Diéras, M Robson, et al.
Elife|November 12, 2020
A versatile oblique plane microscope for large-scale and high-resolution imaging of subcellular dynamicsEtai Sapoznik, Bo-Jui Chang, Jaewon Huh, et al.
Gynecologic Oncology|January 29, 2019
53BP1 as a potential predictor of response in PARP inhibitor-treated homologous recombination-deficient ovarian cancerRachel M Hurley, Andrea E Wahner Hendrickson, Daniel W Visscher, et al.
Cancer Chemotherapy and Pharmacology|April 18, 2022
A phase 1 and pharmacodynamic study of chronically-dosed, single-agent veliparib (ABT-888) in patients with BRCA1- or BRCA2-mutated cancer or platinum-refractory ovarian or triple-negative breast cancerJulia Manzo, Shannon Puhalla, Shalu Pahuja, et al.
Nature Medicine|June 8, 2023
An integrated cell atlas of the lung in health and diseaseLisa Sikkema, Ciro Ramírez-Suástegui, Daniel C Strobl, et al.
Pageof 55